USPTO serial 99063519
BIVISION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WUDARSKY, MINDY CHEK
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with BIVISION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $125
Owner
Bivision Pharmaceuticals(Shanghai),Inc.
Shanghai, CN
Other trademarks owned by Bivision Pharmaceuticals(Shanghai),Inc.
Bivision Pharmaceuticals(Shanghai),Inc.
Shanghai, CN
Other trademarks owned by Bivision Pharmaceuticals(Shanghai),Inc.
Bivision Pharmaceuticals(Nanjing),Inc.
Nanjing, CN
Other trademarks owned by Bivision Pharmaceuticals(Nanjing),Inc.
Bivision Pharmaceuticals(Nanjing),Inc.
Nanjing, CN
Other trademarks owned by Bivision Pharmaceuticals(Nanjing),Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anthony Claiborne
Anthony Claiborne Claiborne Patent Law Services849 136th Ave. N.E.Bellevue, WA 98005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Diagnostic reagents for medicinal use; Tumor suppressing agents; Diagnostic radiopharmaceutical agent for use in PET imaging; Pharmaceutical preparations for use in urology; Pharmaceutical products for the treatment of cancer; Diagnostic radiopharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bivision Pharmaceuticals(Shanghai),Inc.
- Other trademarks owned by Bivision Pharmaceuticals(Shanghai),Inc.
- Other trademarks owned by Bivision Pharmaceuticals(Nanjing),Inc.
- Other trademarks owned by Bivision Pharmaceuticals(Nanjing),Inc.
- Other trademarks in Class 005
- Similar marks named BIVISION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 28, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 28, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 28, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 4, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2025 | NWAP | NEW APPLICATION ENTERED | — |